Lenalidomide in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT00439231 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

NIH

Sponsor class

Conditions

Chronic Lymphocytic Leukemia (CLL)
Small Lymphocytic Lymphoma

Interventions

DRUG: Lenalidomide

Sponsor

Georg Aue, M.D.

Collaborators

[object Object]